GB2093027A — 2-amino-3-(halobenzoyl)-methylphenylacetic acids, esters and salts thereof
Assigned to AH Robins Co Inc · Expires 1982-08-25 · 44y expired
What this patent protects
Novel 2-amino-3-(halobenzoyl)- methylphenylacetic acids, esters and salts having the formula: <IMAGE> wherein R represents a hydrogen atom, a lower alkyl group or a pharmaceutically acceptable metal cation, Y represents a halogen atom and n is an integer from 1 to 3 are p…
USPTO Abstract
Novel 2-amino-3-(halobenzoyl)- methylphenylacetic acids, esters and salts having the formula: <IMAGE> wherein R represents a hydrogen atom, a lower alkyl group or a pharmaceutically acceptable metal cation, Y represents a halogen atom and n is an integer from 1 to 3 are provided. The compounds exhibit outstanding anti-inflammatory and analgesic activity in warm blooded animals with minimal gastro-intestinal toxicity.
Drugs covered by this patent
- Nevanac (NEPAFENAC) · Harrow Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.